Free Trial

Revolution Medicines (RVMD) SEC Filings & 10K Form

Revolution Medicines logo
$44.06 +0.77 (+1.78%)
(As of 12/20/2024 05:31 PM ET)

Recent Revolution Medicines SEC Filings

DateFilerForm TypeView
12/20/2024
3:50 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:08 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:09 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:06 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:07 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:07 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
8:35 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
7:42 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
7:01 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
6:39 PM
Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:57 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2024
3:18 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
8:37 PM
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form FWP
12/02/2024
4:21 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 424B5
12/02/2024
6:30 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:20 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
9:52 AM
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/06/2024
4:07 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:05 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:10 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2024
3:42 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:42 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:43 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
3:30 PM
Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/25/2024
5:43 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
5:05 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:07 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:29 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:30 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:30 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:31 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
7:03 AM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2024
3:16 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:23 PM
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Weber Barbara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
3:33 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:33 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:16 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:17 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:17 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:18 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:18 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
I was wrong. Dead wrong. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

09/16/2024
6:06 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
5:41 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
5:22 PM
Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:37 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:15 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:24 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
3:23 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
3:15 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:48 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:34 PM
Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2024
4:34 PM
Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:07 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 424B5
08/02/2024
4:35 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:29 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
4:05 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2024
3:27 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
7:03 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
3:35 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:36 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:36 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
3:36 PM
Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
3:36 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:19 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:19 PM
Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/28/2024
4:05 PM
Horning Sandra (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4/A
06/28/2024
4:06 PM
Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4/A
06/28/2024
4:06 PM
Borisy Alexis (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4/A
06/28/2024
4:07 PM
Kim Lorence H. (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4/A
06/28/2024
4:07 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
Form 4/A
06/28/2024
4:08 PM
Borellini Flavia (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4/A
06/28/2024
4:09 PM
ANDERSON ELIZABETH M (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4/A
06/27/2024
5:48 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2024
3:20 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2024
3:20 PM
ANDERSON ELIZABETH M (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
3:20 PM
Borellini Flavia (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
3:20 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
3:21 PM
Kim Lorence H. (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
3:21 PM
Borisy Alexis (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
3:22 PM
Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
3:23 PM
Horning Sandra (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
10:28 AM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
4:47 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
4:37 PM
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Wei Lin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
4:20 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
4:08 PM
Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
3:56 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
3:31 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
3:18 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:40 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/21/2024
3:31 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
AI breakthrough about to upend industry (Ad)

Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.

05/08/2024
4:11 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form S-3ASR
05/03/2024
6:36 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2024
3:30 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form DEF 14A
04/25/2024
3:35 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form DEFA14A
04/12/2024
7:08 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:23 PM
Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:21 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
3:21 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
3:21 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RVMD) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners